(Q34062636)

30 July 2017

1 reference

title

Transdermal delivery of antisense compounds (English)

1 reference

30 July 2017

Brand RM

1

1 reference

30 July 2017

Iversen PL

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Advanced Drug Delivery Reviews

30 July 2017

published in

1 reference

30 July 2017

volume

44

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

51-57

1 reference

Penetration of oligonucleotides into mouse organism through mucosa and skin

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Iontophoretic delivery of oligonucleotide derivatives into mouse tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Transdermal transport of DNA antisense oligonucleotides by electroporation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Solute molecular size and transdermal iontophoresis across excised human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Iontophoretic delivery of a telomeric oligonucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

The Clearance and Degradation of Oligodeoxynucleotides Following Intravenous Injection into Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

A novel oligodeoxynucleotide inhibitor of thrombin. II. Pharmacokinetics in the cynomolgus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects*

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Effects of size and sequence on the iontophoretic delivery of oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne Pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Morpholino antisense oligomers: design, preparation, and properties

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

A Specificity Comparison of Four Antisense Types: Morpholino, 2′-O-Methyl RNA, DNA, and Phosphorothioate DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Characteristics of oligonucleotide uptake in human keratinocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

An experimental model for interpreting percutaneous penetration of oligonucleotides that incorporates the role of keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Iontophoresis and electroporation: comparisons and contrasts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Ultrasound-mediated transdermal protein delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Strategies to enhance permeability via stratum corneum lipid pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Structural Basis for the Barrier Abnormality Following Inhibition of HMG CoA Reductase in Murine Epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900083-1

7 January 2021

10.1016/S0169-409X(00)00083-1

Identifiers

DOI

1 reference

30 July 2017

1 reference